+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

L

Actively Recruiting

Researchers are collecting information from people with Progressive Familial Intrahepatic Cholestasis PFIC, a rare liver condition that causes itching and yellowing of the skin. The study focuses on individuals using odevixibat, a medicine approved in several regions including South Korea, the EU, and the US, to help manage PFIC symptoms. This observational study aims to understand the long-term safety and effectiveness of odevixibat in daily use. Participants in this study are those who have been prescribed odevixibat and may be currently taking it or starting treatment. The study observes participants over approximately 7 years, tracking their health while they use odevixibat in regular care settings. There are no additional experimental treatments instead, the study records real-world outcomes as participants continue their prescribed medication. During the study, researchers gather data on adverse events and monitor important health outcomes such as survival without surgery, liver transplant, or other complications. The study collects this information from the time participants consent until the end of data collection, which lasts about 7 years. Participants will have periodic assessments as part of their routine care, and the study aims to provide a detailed view of odevixibats long-term use in people with PFIC.

All AgesAll Genders
5 locations